Susquehanna Fundamental Investments’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-25,964
Closed -$908K 954
2025
Q1
$908K Sell
25,964
-26,110
-50% -$1.07M 0.01% 712
2024
Q4
$2.32M Buy
+52,074
New +$2.13M 0.03% 494
2024
Q2
$5.16M Buy
155,456
+130,880
+533% +$5.35M 0.12% 228
2024
Q1
$1.18M Buy
+24,576
New +$1.43M 0.06% 319
2023
Q3
Sell
-5,515
Closed -$457K 550
2023
Q2
$457K Sell
5,515
-881
-14% -$77.1K 0.02% 454
2023
Q1
$570K Sell
6,396
-42,593
-87% -$3.71M 0.01% 647
2022
Q4
$4.2M Sell
48,989
-69,710
-59% -$5.9M 0.07% 334
2022
Q3
$8.48M Buy
+118,699
New +$10.6M 0.14% 208
2022
Q1
$7.37M Buy
65,540
+8,700
+15% +$927K 0.14% 198
2021
Q4
$7.67M Sell
56,840
-9,530
-14% -$1.33M 0.2% 122
2021
Q3
$9.37M Buy
66,370
+34,990
+112% +$4.7M 0.17% 149
2021
Q2
$4.02M Buy
31,380
+22,110
+239% +$2.6M 0.07% 374
2021
Q1
$1.19M Sell
9,270
-25,248
-73% -$4.66M 0.02% 821
2020
Q4
$6.2M Buy
+34,518
New +$7.67M 0.11% 249

Other funds holding QDEL

Susquehanna Fundamental Investments's QDEL Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of QuidelOrtho (QDEL) in Q2 2025, closing a stake of 25,964 shares — an estimated $908K sold.

Susquehanna Fundamental Investments first reported a position in QDEL in Q4 2020 and held it in 14 quarters. The position peaked at $9.37M in Q3 2021. 264 funds tracked by Wall St. Rank hold QDEL as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining QuidelOrtho position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 25,964 QuidelOrtho shares in Q2 2025, an estimated $908K.
  • Susquehanna Fundamental Investments first reported a position in QuidelOrtho in Q4 2020 and held it in 14 quarters.
  • Susquehanna Fundamental Investments's QuidelOrtho position peaked at $9.37M in Q3 2021.
  • 264 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.